HLA-DRB1 rs2101521: Allergic Sensitization and Immune Traits
rs2101521 is a single-nucleotide polymorphism located in the human leukocyte antigen (HLA) class II genomic region near the HLA-DRB1 gene. Genome-wide association studies have identified statistical links between this variant and altered immune reactivity, most notably allergic sensitization phenotypes such as reactions to pollen and animal dander. However, overall clinical evidence remains limited, and possessing specific alleles does not directly cause or diagnose allergic conditions.
What each genotype means
Typical allergic sensitization risk
You carry two copies of the common G allele at rs2101521 near HLA-DRB1. Genome-wide association studies show that this baseline genotype is associated with typical population-level odds of allergic sensitization to environmental allergens like pollen, dust mites, and animal dander. Because this variant is situated in the complex HLA region and evidence is non-diagnostic, carrying this genotype does not guarantee protection from allergies.
Carried by approximately 45% to 50% of people of European ancestry and roughly 65% to 70% of individuals of East Asian ancestry.
Slightly increased allergic sensitization odds
You have one copy of the A risk allele and one copy of the G allele at rs2101521. Large-scale genetic meta-analyses have linked the A allele to modest increases in the risk of allergic sensitization across multiple environmental antigens, such as grass pollen and cat dander. However, this statistical correlation represents a small individual shift in relative risk rather than a direct clinical cause of allergic disease.
Found in about 40% to 45% of individuals of European ancestry and roughly 25% to 30% of people of East Asian ancestry.
Elevated allergic sensitization odds
You carry two copies of the A risk allele at rs2101521 within the HLA class II locus. Published research correlates this genotype with higher statistical susceptibility to allergic sensitization and self-reported allergies compared to non-carriers. Genetic variations in the HLA region confer only a small component of total allergy risk, with non-genetic environmental exposures playing a substantial role.
Present in roughly 8% to 10% of European populations and approximately 2% to 4% of East Asian populations.
Genomic Location and the HLA Class II Region
The single-nucleotide polymorphism rs2101521 is situated on chromosome 6 within the major histocompatibility complex (MHC), one of the most genetically diverse and gene-dense regions of the human genome. Specifically, rs2101521 maps to the HLA class II interval, residing in close proximity to or within the intronic sequence of the HLA-DRB1 locus. Due to the high degree of linkage disequilibrium in the HLA region, single-nucleotide variants often co-occur with larger classical HLA haplotypes. Consequently, variants like rs2101521 frequently act as genetic tags or markers for surrounding regulatory or protein-coding sequences rather than acting as isolated functional mutations. Genomic catalogs classify rs2101521 primarily as a non-coding or intronic regulatory marker.
The Biological Role of HLA-DRB1
The HLA-DRB1 gene encodes the beta chain of the heterodimeric human leukocyte antigen-DR (HLA-DR) protein complex. Paired with an alpha chain, this membrane-bound receptor is expressed predominantly on professional antigen-presenting cells, including dendritic cells, B lymphocytes, and macrophages. The primary physiological function of HLA-DR is to present peptide fragments derived from extracellular antigens to CD4-positive helper T cells. This molecular interaction plays a foundational role in initiating adaptive immune responses, orchestrating helper T-cell activation, and driving immunoglobulin class-switching. Alterations in antigen-binding groove architecture or regulatory elements influencing HLA-DR expression can reshape immune tolerance and shift baseline vulnerability to both autoimmune disease and exaggerated hypersensitivity reactions.
Association with Allergic Sensitization
Large-scale genome-wide association studies (GWAS) have evaluated rs2101521 in the context of atopic diseases and immune response variations. Statistical associations have linked the variant with multiple allergic sensitization phenotypes, including elevated specific IgE antibody responses against common airborne environmental allergens like grass pollen, tree pollen, and animal dander. Outside of atopy, specific candidate gene investigations, such as studies in pediatric ocular inflammatory conditions, have observed modest frequency shifts of alleles at this locus. However, the evidence strength supporting a standalone causal role for rs2101521 remains limited. Because the MHC exhibits extensive linkage disequilibrium, rs2101521 likely serves as a proxy marker reflecting complex ancestral HLA-DR and HLA-DQ haplotypes rather than exerting an independent biological effect.
Interpreting Results: What This Means for Consumers
Understanding a genetic result for rs2101521 requires distinguishing between statistical association and clinical diagnosis. Allergic conditions such as allergic rhinitis, eczema, asthma, and environmental allergies are multifactorial traits governed by hundreds of common genetic variants interacting with environmental exposures, microbiome health, and lifestyle. Harboring one or two alleles associated with heightened sensitization does not mean an individual will develop clinical allergies, nor does the absence of these alleles confer immunity against environmental triggers. Genetic variations at rs2101521 cannot replace standard clinical evaluations, such as skin prick testing or allergen-specific serum IgE measurements. Individuals experiencing allergic symptoms should seek direct guidance from a board-certified allergist or clinical immunologist rather than relying on DNA profiling.
How common is this variant?
The minor allele frequency for rs2101521 varies across ancestral backgrounds, documented at approximately 0.30 in populations of European descent and roughly 0.18 in individuals of East Asian ancestry.
Frequently asked questions
Can testing rs2101521 diagnose my pollen or pet allergies?
No, rs2101521 is not a diagnostic test. While genome-wide association studies link this marker to small statistical shifts in allergic sensitization, clinical allergy diagnosis requires a professional assessment combining symptoms, medical history, and clinical tools such as skin prick testing or serum-specific IgE blood tests.
Does carrying the A allele mean I will definitely develop allergies?
Not at all. Carrying the A allele only reflects a slight statistical correlation identified across large population datasets. Many individuals who carry this allele never experience environmental allergies, as allergies develop from complex interactions between hundreds of genes and environmental triggers.
Why is the HLA region so frequently linked to immune conditions?
The HLA complex contains the genes responsible for presenting foreign antigens to the immune system's T cells. Because these proteins directly determine how the body recognizes foreign substances, natural variations across this genomic cluster can alter baseline immune sensitivity, allergic reactions, and autoimmune risks.
Should I change my allergy medications based on my rs2101521 genotype?
No. rs2101521 has no established pharmacogenomic role and does not alter how allergy medications, such as antihistamines or nasal corticosteroids, are processed by the body. You should never alter dosages or stop treatments without consulting your healthcare provider or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2101521?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HLA-DRB1
This variant is a well-established genetic risk factor for multiple sclerosis, specifically associated with the HLA-DRB1*15:01 allele.
This variant is a well-established marker in the HLA region significantly associated with susceptibility to rheumatoid arthritis and other immune-mediated conditions.
This variant is a lead signal in the HLA region associated with susceptibility to nodular sclerosis Hodgkin lymphoma.
Variant in the HLA-DRB1 region associated with inflammatory bowel disease (IBD) severity and clinical outcomes.
This variant is a significant genetic marker for susceptibility to Parkinson's disease.
This SNP is linked to immune response regulation and autoimmune disease risk.